Koers Cannabics Pharmaceuticals Inc. Other OTC
Aandelen
CNBX
US13764M1009
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | 410K 378K | Marktkapitalisatie | 353K 325K |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -3 mln. -2,77 mln. | Nettowinst (verlies) 2023 | -3 mln. -2,77 mln. | EV/omzet 2022 | - |
Nettoschuld 2022 | 1,64 mln. 1,51 mln. | Nettoschuld 2023 | 1,21 mln. 1,12 mln. | EV/omzet 2023 | 3,82 x |
K/w-verhouding 2022 |
-1,12
x | K/w-verhouding 2023 |
-0,04
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Eyal Barad
FOU | Founder | 58 | 15-09-04 |
Gabriel Yariv
CHM | Chairman | 47 | 07-10-19 |
Uri Ben-Or
DFI | Director of Finance/CFO | 52 | 05-11-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Eyal Barad
FOU | Founder | 58 | 15-09-04 |
Gabriel Yariv
CHM | Chairman | 47 | 07-10-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,68% | 121 mld. | |
+18,07% | 110 mld. | |
+17,23% | 25,98 mld. | |
-24,01% | 19,27 mld. | |
-18,56% | 15,99 mld. | |
-18,51% | 15,66 mld. | |
-47,75% | 14,5 mld. | |
+57,65% | 14,47 mld. | |
+5,80% | 13,91 mld. |